This inventor holds 3 USPTO granted patents and 3 EPO patents. Top assignees: Welichem Biotech Inc., Weihe Pharma{grave Over (c)}euticals Co. Ltd.. Active years: 2011-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 8 
1 out of 1 Years Active: 2011-2015
Title: The Innovative Contributions of Bin Li
Introduction
Bin Li is a notable inventor based in Burnaby, Canada. He has made significant contributions to the field of therapeutic compounds, particularly in the development of dithiolopyrrolone compounds. With a total of 3 patents to his name, his work focuses on innovative treatments for various diseases, including cancer and microbial infections.
Latest Patents
One of Bin Li's latest patents is titled "Dithiolopyrrolones with therapeutic activity." This invention provides novel dithiolopyrrolone compounds and their salts, which are useful as treatments for cancer and other proliferative diseases. The patent also includes therapeutic compositions comprising particularly useful types of dithiolopyrrolones, their salts, and methods of using these compounds, especially in treating proliferative diseases such as cancer. Another significant patent is "Dithiolopyrrolones compounds and their therapeutic applications." This invention presents dithiolopyrrolone compounds of a specific general formula, which are useful for preventing and treating microbial infections, such as HIV, and for addressing blood disorders like neutropenia. These compounds are particularly valuable for manufacturing medicaments aimed at increasing white blood cell counts.
Career Highlights
Throughout his career, Bin Li has worked with various companies, including Welichem Biotech Inc. and Weihe Pharmaceuticals Co. Ltd. His experience in these organizations has contributed to his expertise in the development of therapeutic compounds.
Collaborations
Bin Li has collaborated with notable coworkers, including Genhui Chen and Jianxiong Li. Their combined efforts have further advanced the research and development of innovative therapeutic solutions.
Conclusion
Bin Li's contributions to the field of therapeutic compounds demonstrate his commitment to innovation and improving healthcare outcomes. His patents reflect a deep understanding of medicinal chemistry and a dedication to addressing critical health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile